YOUR SHOPPING CART
Rapidly effective
– Significant improvement in itch 2 hours after first dose
– Reduces pruritus and inflammation in dogs
with allergic dermatitis and atopic dermatitis
Proven safety and efficacy
– At least 10 X more selective for JAK1, the
primary driver of itch and inflammation
– High selectivity for JAK 1 minimises
interference with beneficial functions
of other JAKs
– Allows adequate response to vaccination when
dosed at 3 X maximum recommended dose
– Well tolerated in dogs from 6 months of age
Simple and convenient
– Once daily dosing from day 1
– Broadest age and weight range – the only JAK
inhibitor for use in dogs from 6 months of age
Registered pursuant to the ACVM Act 1997, No. A012149